NCT00312702View on ClinicalTrials.gov

Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

October 31, 2006

Study Completion Date

April 30, 2007

Conditions
MalariaPlasmodium Falciparum Malaria
Interventions
BIOLOGICAL

Falciparum Malaria Protein 11 with AS02A adjuvant

vaccine

Trial Locations (1)

20910

Walter Reed Army Institute of Research, Silver Spring

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

The PATH Malaria Vaccine Initiative (MVI)

OTHER

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

lead

U.S. Army Medical Research and Development Command

FED

NCT00312702 - Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America | Biotech Hunter | Biotech Hunter